We are live on ! Find out more

1,881 hedge funds and large institutions have $91B invested in Amgen in 2019 Q1 according to their latest regulatory filings, with 93 funds opening new positions, 721 increasing their positions, 807 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% more ownership

Funds ownership: 76.95% → 77.02% (+0.07%)

0% less funds holding

Funds holding: 1,888 → 1,881 (-7)

11% less repeat investments, than reductions

Existing positions increased: 721 | Existing positions reduced: 807

17% less first-time investments, than exits

New positions opened: 93 | Existing positions closed: 112

47% less funds holding in top 10

Funds holding in top 10: 133 → 71 (-62)

50% less call options, than puts

Call options by funds: $783M | Put options by funds: $1.58B

51% less capital inflows, than outflows

Capital inflows: $2.91B | Capital outflows: $5.96B

Holders
1,881
Holders Change
-7
Holders Change %
-0.37%
% of All Funds
40.6%
Holding in Top 10
71
Holding in Top 10 Change
-62
Holding in Top 10 Change %
-46.62%
% of All Funds
1.53%
New
93
Increased
721
Reduced
807
Closed
112
Calls
$783​M
Puts
$1.58​B
Net Calls
-⁠$796​M
Net Calls Change
-⁠$423​M

AMGN Hedge Fund Activity: Q1 2019 in Review

1,881 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2019, worth a combined $91B — down 4.6% from $95.4B a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of AMGN and 93 opened new positions — a net loss of 19 holders — while 807 trimmed existing stakes and 721 added.

The largest buyer was Wells Fargo, adding an estimated $268M. The largest seller was Fidelity Investments, cutting an estimated $1.48B.

  • 1,881 institutional investors held Amgen (AMGN) as of Q1 2019, down from 1,888 in Q4 2018.
  • Funds reported $91B of Amgen stock for Q1 2019, down 4.6% quarter-over-quarter.
  • 93 funds opened new Amgen positions in Q1 2019 and 112 closed out, a net change of -19 holders.
  • The largest Amgen buyer in Q1 2019 was Wells Fargo, an estimated $268M added.
  • The largest Amgen seller in Q1 2019 was Fidelity Investments, an estimated $1.48B sold.

Based on aggregated 13F filings for Q1 2019.